Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1945 Aug 1;82(2):107-18.
doi: 10.1084/jem.82.2.107.

BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : II. COMPARATIVE BACTERIOSTATIC EFFECT OF NORMAL WHOLE BLOOD FROM DIFFERENT ANIMAL SPECIES IN THE PRESENCE OF HUMAN CONVALESCENT SERA

Affiliations

BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : II. COMPARATIVE BACTERIOSTATIC EFFECT OF NORMAL WHOLE BLOOD FROM DIFFERENT ANIMAL SPECIES IN THE PRESENCE OF HUMAN CONVALESCENT SERA

S Rothbard. J Exp Med. .

Abstract

1. Heparin was more satisfactory for preventing blood from clotting than defibrination, potassium and ammonium oxalate, or sodium citrate in bacteriostasis of group A streptococci in the presence of streptococcal antibodies in convalescent serum. 2. Blood from rabbit, guinea pig, or sheep could not be substituted for human blood in promoting bacteriostasis when human antibody was used. Mixtures of human leukocytes and plasma of each of these animals or of animal leukocytes and human plasma were also not effective with human antibody. 3. Complement, leukocytes, and a thermostable factor which was found in human plasma were essential in the indirect bacteriostatic technique employed for the inhibition of streptococcal growth in the presence of convalescent human serum. 4. The thermostable component was active in human serum, as well as in plasma, in 1:12 dilution, withstood storage at 4 degrees C. for at least 7 weeks, and was destroyed by heating at 70 degrees C. for 30 minutes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1930 Apr 30;51(5):675-84 - PubMed
    1. J Exp Med. 1945 Aug 1;82(2):93-106 - PubMed
    1. J Exp Med. 1933 Mar 31;57(4):527-47 - PubMed
    1. J Clin Invest. 1944 Mar;23(2):151-61 - PubMed
    1. J Exp Med. 1945 Aug 1;82(2):119-32 - PubMed